Kanizsai Dorottya Hospital
About Kanizsai Dorottya Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
7
Bayer
6
Boehringer Ingelheim
3
Celgene
3
Gilead Sciences
3
Pierre Fabre Medicament
2
Basilea Pharmaceutica
1
Daiichi Sankyo, Inc.
1
Gan and Lee Pharmaceuticals, USA
1
Heart Initiative
1
Janssen Research & Development, LLC
1
Clinical Trials at Kanizsai Dorottya Hospital
During the past decade, Kanizsai Dorottya Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 9 clinical trials were completed, i.e. on
average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
2011-11-01
2013-10-01
Completed
465
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
2012-01-01
2013-08-01
Completed
431
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
2012-06-01
2013-10-01
Completed
442
Effect of F2695 on Functional Recovery After Ischemic Stroke
2012-07-01
2015-02-01
Completed
532
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
2015-11-05
2019-03-31
Completed
7,797
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
2016-08-01
2023-01-11
Completed
329
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kanizsai Dorottya Hospital" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Bayer" with 6 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences"
with 3 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kanizsai Dorottya Hospital"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at Kanizsai Dorottya Hospital
According to Clinical.Site data, the most researched conditions in "Kanizsai Dorottya Hospital" are
"Type 2 Diabetes Mellitus" (5 trials), "Crohn Disease" (4 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Kanizsai Dorottya Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kanizsai Dorottya Hospital
Most popular intervention types in "Kanizsai Dorottya Hospital" are "Drug" (30 trials), "Other" (7 trials), "Behavioral" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Diet" (3 trials), "Dulaglutide" (3 trials), "Exercise" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Kanizsai Dorottya Hospital
The vast majority of trials in "Kanizsai Dorottya Hospital" are
34 trials for "All" genders.
Clinical Trials Status at Kanizsai Dorottya Hospital
Currently, there are NaN active trials in "Kanizsai Dorottya Hospital".
undefined are not yet recruiting,
6 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Kanizsai Dorottya Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kanizsai Dorottya Hospital, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".